THE NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH1

1972 ◽  
Vol 35 (6) ◽  
pp. 335-339
Author(s):  
Dale R. Lindsay
Keyword(s):  
Research And Development ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
Government Agencies ◽  
Research Centers ◽  
Academic Institutions ◽  
Hazardous Chemicals ◽  
Toxicological Research ◽  
The Many ◽  
National Resource

On January 26, 1971, President Nixon announced the establishment of a National Center for Toxicological Research (NCTR) at Pine Bluff, Arkansas. The Food and Drug Administration will administer tins facility in a manner that is responsive to the needs of the FDA, EPA, and other government agencies, when their programs require research and development suitable to the Center, The Center is to be a national resource to be shared and utilized by appropriate government agencies, academic institutions, and industry. It will not duplicate the research capabilities of existing toxicological centers, rather it will build upon this existing capability and technology and augment existing research programs by undertaking projects which are not possible at other research centers. The author discusses problems that have created the need for this Center and approaches that will be used to try to determine the risk that man runs in his every day exposure to the many hazardous chemicals in his environment.

EYE ON CHINA

2016 ◽  
Vol 20 (04) ◽  
pp. 4-11
Keyword(s):  
Cervical Cancer ◽  
Stem Cells ◽  
New Zealand ◽  
Human Papilloma Virus ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
Research Centers ◽  
Joint Research ◽  
Papilloma Virus ◽  
Clinical Genomics

Clinical Genomics and its Exclusive China Partner BioChain Group Receive CFDA Approval for InSure® FIT™ in China. China-U.S. Team Uses Stem Cells in Cataract Treatment. Celsion Corporation Announces Launch of the OPTIMA Study in China. 3SBio's PEG-irinotecan Wins IND Approval from China FDA. New Zealand to Fund Joint Research Centers with China. Roche Receives China Food and Drug Administration (CFDA) Approval for the CINtec® PLUS Cytology Test to Help Prevent Women from Developing Cervical Cancer. Infographic: Cervical Cancer & Human Papilloma Virus – What You Do Not Know May Save Your Life. Transgenic Monkeys for Autism Study in China - Featuring Dr. Zilong Qiu.

scholarly journals ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research.

2003 ◽  
Vol 111 (15) ◽  
pp. 1819-1826 ◽  
Author(s):  
Weida Tong ◽  
Xiaoxi Cao ◽  
Stephen Harris ◽  
Hongmei Sun ◽  
Hong Fang ◽  
...  
Keyword(s):  
Drug Administration ◽  
Food And Drug Administration ◽  
Toxicological Research ◽  
The U.S

scholarly journals On instabilities of deep learning in image reconstruction and the potential costs of AI

2020 ◽  
Vol 117 (48) ◽  
pp. 30088-30095 ◽  
Author(s):  
Vegard Antun ◽  
Francesco Renna ◽  
Clarice Poon ◽  
Ben Adcock ◽  
Anders C. Hansen
Keyword(s):  
Deep Learning ◽  
Structural Change ◽  
Image Reconstruction ◽  
Image Classification ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
Stability Test ◽  
Reconstructed Image ◽  
Government Agencies ◽  
Learning Methods

Deep learning, due to its unprecedented success in tasks such as image classification, has emerged as a new tool in image reconstruction with potential to change the field. In this paper, we demonstrate a crucial phenomenon: Deep learning typically yields unstable methods for image reconstruction. The instabilities usually occur in several forms: 1) Certain tiny, almost undetectable perturbations, both in the image and sampling domain, may result in severe artefacts in the reconstruction; 2) a small structural change, for example, a tumor, may not be captured in the reconstructed image; and 3) (a counterintuitive type of instability) more samples may yield poorer performance. Our stability test with algorithms and easy-to-use software detects the instability phenomena. The test is aimed at researchers, to test their networks for instabilities, and for government agencies, such as the Food and Drug Administration (FDA), to secure safe use of deep learning methods.

scholarly journals ArrayTrack - Supporting Toxicogenomic Research at the U.S. Food and Drug Administration National Center for Toxicological Research

2003 ◽  
Vol 111 (15) ◽  
Author(s):  
Weida Tong ◽  
Xiaoxi Cao ◽  
Stephen Harris ◽  
Hongmei Sun ◽  
Hong Fang ◽  
...  
Keyword(s):  
Drug Administration ◽  
Food And Drug Administration ◽  
Toxicological Research ◽  
The U.S

scholarly journals Export compliance for life sciences

2008 ◽  
Vol 14 (2) ◽  
Author(s):  
John Avellanet
Keyword(s):  
Research And Development ◽  
Medical Device ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
Life Sciences ◽  
Regulatory Compliance ◽  
Technological Knowledge ◽  
Types Of Knowledge ◽  
Export Compliance ◽  
Compliance Programme

Long before worrying about US Food and Drug Administration compliance, organisations that work with foreign employees, contractors, vendors or partners need to be concerned with the importation and exportation of technological knowledge – the so-called ‘deemed exports’. This is particularly apt for executives in the biopharmaceutical, biotechnology and medical device fields who outsource research and development overseas or who hire non-US citizens. US export regulations have strict guidelines on the types of knowledge that cannot be shared with non-US citizens and carry harsh penalties for non-compliance that fall equally on the organisation in question and its executives who ought to have known better. This paper presents an eight-step strategy to develop a regulatory compliance programme that meets US export compliance regulations.

Sign in / Sign up

Export Citation Format

Share Document